Ventus Therapeutics is using computational tools to unlock elusive drug targets that address human disease.
Leadership
Marcelo Bigal
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas
Insights
Q&A
Why Ventus Therapeutics always puts patients first
For CEO Marcelo Bigal, it comes down to everyone understanding the company’s core mission
Vision Fund Team